Therapy of advanced gastrointestinal cancer with 1-3-bis-(2-chlorethyl)-1-nitrosourea (BCNU).
D000230:Adenocarcinoma / Q000188:drug therapy*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D009603:Nitroso Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D014508:Urea / Q000008:administration & dosage* / Q000009:adverse effects
D009603:Nitroso Compounds; D014508:Urea